Cargando…
P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431027/ http://dx.doi.org/10.1097/01.HS9.0000846540.61863.d3 |
| _version_ | 1784779940439261184 |
|---|---|
| author | Khwaja, J. Bomsztyk, J. Mahmood, S. Wisniowski, B. Shah, R. Tailor, A. Yong, K. Popat, R. Rabin, N. Kyriakou, C. Sive, J. Worthington, S. Hart, A. Dowling, E. Correia, N. Bygrave, C. Rydzewski, A. Jamroziak, K. Wechalekar, A. |
| author_facet | Khwaja, J. Bomsztyk, J. Mahmood, S. Wisniowski, B. Shah, R. Tailor, A. Yong, K. Popat, R. Rabin, N. Kyriakou, C. Sive, J. Worthington, S. Hart, A. Dowling, E. Correia, N. Bygrave, C. Rydzewski, A. Jamroziak, K. Wechalekar, A. |
| author_sort | Khwaja, J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431027 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94310272022-08-31 P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS Khwaja, J. Bomsztyk, J. Mahmood, S. Wisniowski, B. Shah, R. Tailor, A. Yong, K. Popat, R. Rabin, N. Kyriakou, C. Sive, J. Worthington, S. Hart, A. Dowling, E. Correia, N. Bygrave, C. Rydzewski, A. Jamroziak, K. Wechalekar, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431027/ http://dx.doi.org/10.1097/01.HS9.0000846540.61863.d3 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Khwaja, J. Bomsztyk, J. Mahmood, S. Wisniowski, B. Shah, R. Tailor, A. Yong, K. Popat, R. Rabin, N. Kyriakou, C. Sive, J. Worthington, S. Hart, A. Dowling, E. Correia, N. Bygrave, C. Rydzewski, A. Jamroziak, K. Wechalekar, A. P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS |
| title | P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS |
| title_full | P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS |
| title_fullStr | P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS |
| title_full_unstemmed | P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS |
| title_short | P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS |
| title_sort | p918: high responses rates with single agent belantamab mafodotin in relapsed systemic al amyloidosis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431027/ http://dx.doi.org/10.1097/01.HS9.0000846540.61863.d3 |
| work_keys_str_mv | AT khwajaj p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT bomsztykj p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT mahmoods p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT wisniowskib p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT shahr p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT tailora p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT yongk p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT popatr p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT rabinn p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT kyriakouc p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT sivej p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT worthingtons p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT harta p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT dowlinge p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT correian p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT bygravec p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT rydzewskia p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT jamroziakk p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis AT wechalekara p918highresponsesrateswithsingleagentbelantamabmafodotininrelapsedsystemicalamyloidosis |